Product Program year 2023 Source: CMS Open Payments

cobas HBV/HCV/HIV-1 Control Kit

Device Molecular Diagnostics

PDI 00875197006476

Open in the dashboard

General payments

$12,640

41 payments

Research payments

$61,522

3 payments

Through program year 2023, $12,640 in general payments and $61,522 in research payments were reported against cobas HBV/HCV/HIV-1 Control Kit (Molecular Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 General $10,181 17
2023 Research $61,522 3
2022 General $2,459 24

Breakdown

Who paid General payments · program years 2022–2023
  1. Roche Diagnostics Corporation $12,640 41 payments
Top recipients General payments · program year 2023
  1. Ohsu Hospital And Clinics Teaching hospital · OR $5,533 54% · 1 payment
  2. Charles Walworth Fountain Vly, CA $4,101 40% · 4 payments
  3. David Pride Infectious Disease · San Diego, CA $246 2% · 2 payments
  4. Daniel Kuritzkes Internal Medicine · Boston, MA $53 <1% · 1 payment
  5. Kenneth Mayer Infectious Disease · Providence, RI $53 <1% · 1 payment

The top 5 of 12 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Infectious Disease Internal Medicine $375 68% · 4 practitioners
  2. Anatomic Pathology & Clinical Pathology Pathology $61 11% · 3 practitioners
  3. Internal Medicine $53 10% · 1 practitioner
  4. Anatomic Pathology Pathology $37 7% · 1 practitioner
  5. Pediatric Infectious Diseases Pediatrics $22 4% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. Oregon $5,533 54% · 1 recipient
  2. California $4,431 44% · 5 recipients
  3. Massachusetts $53 <1% · 1 recipient
  4. Missouri $53 <1% · 1 recipient
  5. Rhode Island $53 <1% · 1 recipient

The top 5 of 8 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

41 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record